Eileen M. Denovan‐Wright

Cannabidiol is a negative allosteric modulator of the cannabinoid CB ₁ receptor

Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly et al. · British Journal of Pharmacology · 2015 · 960 citations · Full text

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili et al. · British Journal of Pharmacology · 2018 · 304 citations · Full text

Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice

Edgardo Rodríguez-Lebrón, Eileen M. Denovan‐Wright, Kevin Nash et al. · Molecular Therapy · 2005 · 275 citations · Full text

Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington′s disease transgenic mice prior to the onset of motor symptoms

Andrea L.O. Hebb, H.A. Robertson, Eileen M. Denovan‐Wright · Neuroscience · 2004 · 174 citations

Neurodegenerative Diseases, Molecular Neuroscience, Protein Levels +10

Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington’s disease mice

Eileen M. Denovan‐Wright, H.A. Robertson · Neuroscience · 2000 · 168 citations

Genetics, Cannabinoid Pharmacology, Synaptic Signaling +16